Pirfenidone is a medicine used to manage lung scarring. Minimizing the production of building blocks that create stiff tissue, the treatment helps preserve lung flexibility.
Pirfenidone belongs to a class of drugs known as antifibrotic agents, which are designed to slow the formation of excess scar tissue in the lungs. The primary therapeutic role of pirfenidone is to help preserve lung function in people with progressive lung scarring. You'll find this active compound in medicines such as Esbriet.
Pirfenidone is most commonly used for idiopathic pulmonary fibrosis — a condition where lung tissue becomes stiff without a known cause. It can also be considered for other types of interstitial lung disease that lead to similar scarring. Generally, adults whose breathing difficulty is worsening over months may be offered pirfenidone as part of their treatment plan.
After you swallow a tablet, the medicine is absorbed into the bloodstream and reaches the lungs. It works by interfering with the signals that cause normal lung tissue to turn into scar tissue, thereby slowing the thickening and stiffening of the airways.
Pregnant or nursing people, individuals with serious liver or kidney problems, and anyone who has shown an allergy to pirfenidone should discuss alternatives with their healthcare team. Alcohol and some medicines that are processed by the liver can increase the risk of side effects, so check the label of your specific product for detailed interaction information. Keep an eye on any new symptoms and follow the medication's packaging for guidance.
Older adults and people with existing liver disease tend to notice side effects more often. Those taking other medicines that affect liver function may also experience stronger reactions. If you fall into any of these groups, you should watch for changes and report them promptly.
Store pirfenidone tablets at room temperature, away from excess heat, moisture, and direct sunlight. Keep the medication in a tightly sealed container and out of reach of children. Treatment with pirfenidone is usually long-term, so continue as directed unless advised otherwise. For detailed usage, dosing, and administration, refer to the specific medication's clinical information.
This article provides an educational overview of pirfenidone and is not medical advice. Medicines containing this ingredient, such as Esbriet, may differ in formulation, strength, and directions. The information here does not assume liability for any clinical decisions you make. Always review your specific medication's labeling and seek guidance from a qualified healthcare professional for personalized recommendations.
